CJC-1295 acts on the GHRH receptor, while Ipamorelin acts on the ghrelin receptor (GHSR-1a)both on the same pituitary somatotroph cells
Weight loss with GLP-1 therapy is typically gradual rather than dramatic, and glycaemic improvements may take several weeks to become apparent
Across published trials and case series, the most frequent reported events are injection-site reactions (redness, induration, transient discomfort), headache, mild nausea, and temporary fatigue
Clemmensen C, Finan B, Mller TD, DiMarchi RD, Tschp MH, Hofmann SM (2019) Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases
Low blood sugar (hypoglycemia) If combined with insulin or other diabetes medications, theres a risk of dangerously low blood sugar levels